Page last updated: 2024-10-26

9-(2-hydroxy-3-nonyl)adenine and Malignant Melanoma

9-(2-hydroxy-3-nonyl)adenine has been researched along with Malignant Melanoma in 2 studies

9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase

Research Excerpts

ExcerptRelevanceReference
"The prognosis for malignant melanoma is poor; therefore, new diagnostic methods and treatment strategies are urgently needed."1.39Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells. ( Inui, M; Morita, H; Murata, T; Okumura, K; Shimizu, K; Tagawa, T, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hiramoto, K1
Murata, T2
Shimizu, K2
Morita, H2
Inui, M2
Manganiello, VC1
Tagawa, T2
Arai, N1
Okumura, K1

Other Studies

2 other studies available for 9-(2-hydroxy-3-nonyl)adenine and Malignant Melanoma

ArticleYear
Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells.
    Cellular signalling, 2014, Volume: 26, Issue:9

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Cell Line, Tumor; Cell Movement; Cell Proliferation

2014
Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells.
    Oncology reports, 2013, Volume: 29, Issue:4

    Topics: Adenine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Typ

2013